Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AERI
Nasdaq
2834
http://www.aeriepharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aerie Pharmaceuticals Inc
See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc.
- Feb 8th, 2019 6:04 am
Mizuho's 9 Best Biotech Stocks to Buy for 2019
- Feb 5th, 2019 12:25 pm
Aerie Pharmaceuticals Enters Overbought Territory: Is A Drop Coming?
- Feb 4th, 2019 2:56 am
Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies
- Jan 18th, 2019 7:10 am
A Spotlight On Aerie Pharmaceuticals, Inc.’s (NASDAQ:AERI) Fundamentals
- Jan 17th, 2019 9:47 am
Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-1105 (Dexamethasone Intravitreal Implant)
- Jan 17th, 2019 4:30 am
How to spot risky biotech companies and six to avoid now
- Jan 17th, 2019 3:14 am
Aerie's Rhopressa Succeeds in Study on Japanese Patients
- Jan 7th, 2019 2:57 pm
Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Study Supporting Clinical Development in Japan
- Jan 4th, 2019 4:30 am
Aerie Pharmaceuticals Announces Appointment of Ami Bavishi as Director, Investor Relations and Vincent Santucci, Pharm.D., as Director, Scientific Market Access
- Jan 2nd, 2019 4:30 am
Aerie Division's Prospects Have Analysts Bullish On American Eagle
- Dec 12th, 2018 12:48 pm
Hedge Funds Are Selling Aerie Pharmaceuticals Inc (AERI)
- Dec 11th, 2018 10:58 pm
Should You Get Rid of Aerie Pharmaceuticals (AERI) Now?
- Dec 6th, 2018 6:46 am
Investor Expectations to Drive Momentum within Mirati Therapeutics, comScore, Nuance Communications, Carnival, Aerie Pharmaceuticals, and TrueCar — Discovering Underlying Factors of Influence
- Dec 4th, 2018 5:20 am
Scroll